Revolution Med risks weekly loss despite “transformative” FDA approval

Revolution Medicines' stock fell nearly 7% due to profit-taking selling pressure, despite the FDA approval of its innovative anticancer drug.

AI CATALYST SCORE40 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

ANALYSIS HISTORY

RVMD Analysis History (Last 30 Days)

Diagnosed At	Ticker	AI Score	Tier
2026-08-28 16:52:52	RVMD	40	Row	View Report →
2026-08-28 12:15:46	RVMD	85	Mid	View Report →
2026-08-26 15:03:35	RVMD	90	S-Class	View Report →

RELATED REPORTS

Diagnosed At	Ticker	AI Score	Tier
2026-08-30 16:44:38	AMRN	80	Mid	View Report →
2026-08-30 16:36:52	ARWR	85	Mid	View Report →
2026-08-30 15:58:06	ARWR	75	Mid	View Report →
2026-08-29 05:44:07	MRNA	85	Mid	View Report →
2026-08-28 22:58:10	TAK	85	Mid	View Report →
2026-08-28 21:48:20	TAK	75	Mid	View Report →
2026-08-28 14:33:26	CYTK	40	Row	View Report →
2026-08-28 13:31:33	NVAX	75	Mid	View Report →
2026-08-28 12:24:55	AMGN	75	Mid	View Report →
2026-08-28 11:48:30	GILD	85	Mid	View Report →
2026-08-28 11:27:16	LLY	85	Mid	View Report →
2026-08-28 11:19:33	MRNA	40	Row	View Report →
2026-08-28 10:53:40	ROIV	85	Mid	View Report →
2026-08-27 22:07:01	GILD	75	Mid	View Report →
2026-08-27 22:05:30	GILD	90	Mid	View Report →
2026-08-27 15:36:03	CTMX	85	S-Class	View Report →
2026-08-27 08:42:26	JAZZ	50	Row	View Report →
2026-08-27 08:39:50	NVO	45	Row	View Report →
2026-08-27 07:08:21	AZN	85	Mid	View Report →
2026-08-26 15:26:31	ZYME	85	S-Class	View Report →
2026-08-26 14:14:46	ARGX	85	S-Class	View Report →
2026-08-26 12:00:16	SMMT	85	S-Class	View Report →
2026-08-26 11:33:57	LLY	85	Mid	View Report →
2026-08-26 11:33:56	JAZZ	50	Row	View Report →
2026-08-25 18:53:31	APRE	85	S-Class	View Report →
2026-08-25 14:51:51	JAZZ	85	S-Class	View Report →
2026-08-25 14:26:29	MRNA	90	S-Class	View Report →
2026-08-25 14:21:10	LLY	40	Row	View Report →
2026-08-25 13:22:05	LLY	75	Mid	View Report →
2026-08-25 12:33:09	CAPR	85	S-Class	View Report →